OS Therapies Incorporated (OSTX)

OS Therapies Incorporated (OSTX) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $75.8M; returns 1 day +0.0%, 1 week -5.3%, 1 year -30.9%.

OS Therapies Incorporated (OSTX) is a clinical-stage biopharmaceutical company primarily focused on the identification, development, and commercialization of novel treatments for osteosarcoma and other solid tumors. The company operates with two proprietary technology platforms: OST-Lm (Listeria monocytogenes-based immunotherapy) and OST-tADC (tunable antibody-drug conjugate).

Groups OSTX belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Healthcare
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Antibody-Drug Conjugates
• Antibody Therapeutics
• Life Sciences
• Rare Diseases
• Biologics

OSTX financial model: income statement, cash flow and balance sheet